Vitamin D discovery outpaces FDA decision making

BioEssays

Volumn 30, Issue 2, 2008, Pages 173-182

  Marshall, Trevor G ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b California Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; VITAMIN D; VITAMIN D RECEPTOR;

ARTHRITIS; CHRONIC DISEASE; CLINICAL DECISION MAKING; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; FOOD CHAIN; HUMAN; INTESTINE FLORA; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW; TUBERCULOSIS; VITAMIN SUPPLEMENTATION;

CALCIUM; DECISION MAKING; HUMANS; OBESITY; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VITAMIN D;

EID: 38849139804     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20708     Document Type: Review

References (79)

1. Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, et al. 2007. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-811.
2. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912.
3. Gombart AF, Borregaard N, Koeffler HP. 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 19:1067-1077.
4. Viganò P, Lattuada D, Mangioni S, Ermellino L, Vignali M, et al. 2006. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 36:415-424.
5. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, et al. 2005. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19: 2685-2695.
6. Bravo S, Paredes R, Izaurieta P, Lian JB, Stein JL, et al. 2006. The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells. J Cell Biochem 99:995-1000.
7. DHHS Food and Drug Administration. 2007. Food Labeling; Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis. 21 CFR Part 101 [Docket No. 2004P-0464] Federal Register/Vol. 72 No. 3/Friday, January 5, 2007.
8. Center for Drug Evaluation and Research, Food and Drug Administration. 1994. Guidelines for Preclinical and Clinical Evaluation of Agents used in the Prevention and Treatment of Postmenopausal Osteoporosis. April, 1994. Available from URL http://www.fda.gov/cder/Guidance/osteo.pdf Accessed March 12, 2007.
9. Center for Drug Evaluation and Research, Food and Drug Administration. 2004. Draft Guidance for Industry on the Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Post-menopausal Osteoporosis; Request for Comments. Federal Register Feb 11, 2004; Vol 69, No 28. Available from URL http://www.fda.gov/OHRMS/DOCKETS/98fr/04-2999.htm Accessed March 12, 2007.
10. Lehmann B, Knuschke P, Meurer M. 2000. UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in the human keratinooyte line HaCaT. Photochem Photobiol 72:803-809.
11. Lehmann B, Abraham S, Meurer M. 2004. Role for tumor necrosis factor-alpha in UVB-induced conversion of 7-dehydrocholesterol to lalpha, 25-dihydroxyvitamin D3 in cultured keratinocytes. J Steroid Biochem Mol Biol 89-90:561-565.
12. Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. 2006. High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor - Implications of dysregulated vitamin D for diagnosis and treatment of Chronic Disease. In: Stoltz VD, editor. Vitamin D: New Research, Vol. 1. New York: Nova Science Publishers.
13. Lin R, White JH. 2004. The pleiotropic actions of vitamin D. Bioessays 26:21-28.
14. Marshall Trevor. 2007. Molecular Static and Dynamic Analyses reveal Flaw in Murine Model used by US FDA to Detect Drug Carcinogenicity. Available from Nature Precedings. doi:10.1038/npre.2007.52.1 URL http://precedings.nature.com/ documents/52/version/1.
15. Marshall TG. 2007. Molecular Static and Dynamic Analyses Reveal Flaw in Murine Model used by US FDA to Detect Drug Carcinogenicity Abstract presentation, Days of Molecular Medicine, Cambridge MA, May 22-24, 2007 Copy available from URL http://autoimmunityresearch.org/dmm2007/dmm2007-handout.pdf.
16. Vantieghem K, Overbergh L, Carmeliet G, De Haes P, Bouillon R, et al. 2006. UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor. J Cell Biochem 99:229-240.
17. Sakaki T, Kagawa N, Yamamoto K, Inouye K. 2005. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 10:119-134.
18. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. 2004. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101:7711-7715.
19. Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K. 2004. Metabolism of vitamin D by human microsomal CYP2 R1. Biochem Biophys Res Commun 324:451-457.
20. Yamaoka K, Shindo M, Iwasaki K, Yamaoka I, Yamamoto Y, et al. 2006. Multiple co-activator complexes support ligand-induced transactivation function of VDR. Arch Biochem Biophys 460:166-171.
21. Kato S, Fujiki R, Kim MS, Kitagawa H. 2007. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J Steroid Biochem Mol Biol 103:372-380.
22. Takeuchi O, Hoshino K, Akira S. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-5396.
23. González-Zorn B, Senna JP, Fiette L, Shorte S, Testard A, et al. 2005. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect Immun 73:1847-1851.
24. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI. 2007. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75:753-759.
25. Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, et al. 2005. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol 174:5713-5719.
26. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. 2002. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125-25132.
27. Xu Y, Hashizume T, Shuhart MC, Davis CL, Nelson WL, et al. 2006, Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha, 25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol 69:56-65.
28. Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, et al. 2002. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 16:977-986.
29. Li T, Chen W, Chiang JY. 2007. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 48:373-384.
30. Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, et al. 2006. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 116:1703-1712.
31. Xue Y, Chao E, Zuercher WJ, Willson TM, Collins JL, et al. 2007. Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorg Med Chem 15:2156-2166.
32. Marshall TG, Lee RE, Marshall FE. 2006. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model Jan 10, 3:1.
33. Marshall TG. 2006. Molecular genomics offers new insight into the exact mechanism of action of common drugs - ARBs, Statins, and Cortico-steroids, FDA CDER Visiting Professor presentation, March 2006, FDA Biosciences Library, Accession QH447.M27.
34. McCullough ML. 2007. Vitamin D deficiency in pregnancy: bringing the issues to light. J Nutr 137:305-306.
35. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, et al. 2007. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 137:447-452.
36. Tanaka Y, Halloran B, Schnoes HK, DeLuca HF. 1979. In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. Proc Natl Acad Sci USA 76:5033-5035.
37. Steichen JJ, Tsang RC, Gratton TL, Hamstra A, DeLuca HF. 1980. Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N Engl J Med 302:315-319.
38. Gray TK, Lowe W, Lester GE. 1981. Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. Endocr Rev 2:264-274.
39. Holick MF. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S-1688S.
40. Gonzalez G, Alvarado JN, Rojas A, Navarrete C, Velasquez CG, et al. 2007. High prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a worldwide concern. Menopause. Feb 6.
41. Islam MZ, Akhtaruzzaman M, Lamberg-Allardt C. 2006. Hypovitaminosis D is common in both veiled and nonveiled Bangladeshi women. Asia Pac J Clin Nutr 15:81-87.
42. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK. 2006. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84:602-609.
43. Calvo MS, Whiting SJ. 2006. Public health strategies to overcome barriers to optimal vitamin D status in populations with special needs. J Nutr 136:1135-1139.
44. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. 2007. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370:657-666.
45. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al. 2004. Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72-77.
46. Costenbader KH, Feskanich D, Benito-Garcia E, Holmes M, Karlson E. 2007. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis Jul 31; [Epub ahead of print].
47. Autier P, Gandini S. 2007. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737.
48. Freedman DM, Looker AC, Chang SC, Graubard BI. 2007. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594-1602.
49. Kimball SM, Ursell MR, O'Connor P, Vieth R. 2007. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86:645-651.
50. Barnes MS, Bonham MP, Robson PJ, Strain JJ, Lowe-Strong AS, et al. 2007. Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult Scler 13:670-672.
51. Arnson Y, Amital H, Shoenfeld Y. 2007. Vitamin D and autoimmunity, new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137-1142.
52. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832-2838.
53. Bajzer M, Seeley RJ. 2006. Physiology: obesity and gut flora. Nature 444: 1009-1010.
54. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023.
55. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1031.
56. Wehkamp J, Schauber J, Stange EF. 2007. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 23:32-38.
57. Kai-Larsen Y, Bergsson G, Gudmundsson GH, Printz G, Jôrnvall H, et al. 2007. Antimicrobial components of the neonatal gut affected upon colonization. Pediatr Res 61:530-536.
58. Li C, Ford ES, Mokdad AH, Cook S. 2006. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 118:e1390-1398.
59. Caballero B, Clay T, Davis SM, Ethelbah B, Rock BH, et al. 2003. Pathways Study Research Group. Pathways: a school-based, randomized controlled trial for the prevention of obesity in American Indian schoolchildren. Am J Clin Nutr 78:904-905.
60. Reilly JJ, Kelly L, Montgomery C, Williamson A, Fisher A, et al. 2006. Physical activity to prevent obesity in young children: cluster randomised controlled trial. BMJ 333:1041.
61. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, et al. 2007. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 20:817-823.
62. Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, et al. 2006. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2:98-103.
63. O'Connor SM, Taylor CE, Hughes JM. 2006. Emerging infectious determinants of chronic diseases. Emerg Infect Dis 12:1051-1057. Copy available from URL http://www.cdc.gov/ncidod/eid/vol12no07/06-0037.htm.
64. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48-56. Epub 2006 Dec 4.
65. Marshall TG. 2006. VDR Nuclear Receptor Competence is the Key to Recovery from Chronic Inflammatory and Autoimmune Disease. Abstract presentation, Days of Molecular Medicine 2006. Copy available from URL http://autoimmunityresearch. org/karolinska-handout.pdf.
66. Marshall TG, Marshall FE. 2004. Sarcoidosis succumbs to antibiotics - implications for autoimmune disease. Autoimmunity Reviews 3:295-3001.
67. Davies PD, Brown RC, Woodhead JS. 1985. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 40:187-190.
68. Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, et al. 2007. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb) 87:295-302,
69. Wang R, Lai L, Wang S. 2002. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput Aided Mol Des 16:11-26.
70. Obiol-Pardo C, Rubio-Martinez J. 2007. Comparative evaluation of MMPBSA and XSCORE to compute binding free energy in XIAP-peptide complexes. J Chem Inf Model 47:134-142.
71. Brahmachary M, Schönbach C, Yang L, Huang E, Tan SL, et al. 2007. Computational promoter analysis of mouse, rat and human antimicrobial peptide-coding genes. BMC Bioinformatics 18:S8.
72. Marshall TG. 2007. Bacterial Capnine Blocks Transcription of Human Antimicrobial Peptides. Abstract presentation, Metagenomics. Copy available from URL http://autoimmunityresearch.org/transcripts/metagenomics2007pdf.
73. Marshall Trevor. 2007. Bacterial Capnine Blocks Transcription of Human Antimicrobial Peptides. Available from Nature Precedings doi:10.1038/npre.2007. 164.1. URL http://precedings.nature.com/documents/164/version/1.
74. Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, et al. 2007. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther 14:R46.
75. Maddox BK, Keene DR, Sakai LY, Charbonneau NL, Morris NP, et al. 1997. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem 272:30993-30997.
76. Misumi K, Tagami M, Kamimura T, Miyakoshi D, Helal IE, et al. 2006. Urine cartilage oligomeric matrix protein (COMP) measurement is useful in discriminating the osteoarthritic Thoroughbreds. Osteoarthritis Cartilage 14:1174-1180.
77. Momohara S, Yamanaka H, Holledge MM, Mizumura T, Ikari K, et al. 2004. Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage. Mod Rheumatol 14:356-360.
78. Ozbek S, Engel J, Stetefeld J. 2002. Storage function of cartilage oligomeric matrix protein: the crystal structure of the coiled-coil domain in complex with vitamin D(3). EMBO J 15:5960-5968.
79. Hootman JM, Helmick CG. 2006. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 54:226-229.